ATHDX
Price
$27.43
Change
+$0.30 (+1.11%)
Updated
Aug 21 closing price
Net Assets
5.46B
FSMAX
Price
$117.72
Change
-$1.39 (-1.17%)
Updated
Aug 20 closing price
Net Assets
40.08B
Interact to see
Advertisement

ATHDX vs FSMAX

ATHDX vs FSMAX Comparison Chart in %
View a ticker or compare two or three
VS
ATHDX vs. FSMAX commentary
Aug 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATHDX is a Hold and FSMAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSMAX has more cash in the bank: 40.1B vs. ATHDX (5.46B). FSMAX pays higher dividends than ATHDX: FSMAX (0.50) vs ATHDX (0.00). ATHDX was incepted earlier than FSMAX: ATHDX (13 years) vs FSMAX (15 years). ATHDX (0.65) is less costly to investors than FSMAX (0.04). ATHDX is a more actively managed with annual turnover of: 62.00 vs. FSMAX (23.00). ATHDX (0) and FSMAX (0) have matching initial minimum investment requirements. FSMAX annual gain was more profitable for investors over the last year : 23.68 vs. ATHDX (-10.62). FSMAX return over 5 years is better than : 40.14 vs. ATHDX (-14.95).
ATHDXFSMAXATHDX / FSMAX
Total Expense Ratio0.650.041,857%
Annual Report Gross Expense Ratio0.650.041,857%
Fund Existence13 years15 years-
Gain YTD7.10716.93742%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets5.46B40.1B14%
Annual Yield % from dividends0.000.50-
Returns for 1 year-10.6223.68-45%
Returns for 3 years17.3272.7424%
Returns for 5 years-14.9540.14-37%
Returns for 10 years14.82134.4911%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NGEN1.860.10
+5.68%
NervGen Pharma Corp.
SLDB9.300.20
+2.20%
Solid Biosciences
EWTX44.180.89
+2.06%
Edgewise Therapeutics
KEYS316.13-0.38
-0.12%
Keysight Technologies
NHTC1.69-0.03
-1.74%
Natural Health Trends Corp